Reported covered position: Director of Constituent Service, Senator Tom Daschle; Cloakroom Assistant, U.S. Senate Secretary for the Majority; Director of Special Projects/Legislative Assistant, Senator Barbara Boxer; Special Assistant, Senate Environment & Public Works Cmte
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Prescription Pricing for the People Act of 2019
Client: MASIMO CORPORATION · Firm: MASIMO CORPORATION
Support for continuous monitoring of patients taking opioids and patient safety in general; S.1227, HR 2376 - Prescription Pricing for the People Act; S 1895: Lower Health Care Costs Act; Government Purchasing Organizations (GPOs) and anticompetitive behavior; Fiscal Year 2021 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids; COVID-19 Response Efforts and patient monitoring; CARES Act.
Prescription Pricing for the People Act of 2019
Client: MASIMO CORPORATION · Firm: MASIMO CORPORATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MASIMO CORPORATION via MASIMO CORPORATION
2026 · second_quarter · 2T
Issues related to medical device reprocessing; Support for improving patient safety in hospitals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASIMO CORPORATION via MASIMO CORPORATION
2026 · first_quarter · Q1
Source: Senate LDA
Support for continuous monitoring of patients taking opioids and patient safety in general; S.1227, HR 2376 - Prescription Pricing for the People Act; S 1895: Lower Health Care Costs Act; Government Purchasing Organizations (GPOs) and anticompetitive behavior; Fiscal Year 2021 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids; COVID-19 Response Efforts and patient monitoring; CARES Act.
Support for continuous monitoring of patients taking opioids and patient safety in general; S.1227, HR 2376 - Prescription Pricing for the People Act; S 1895: Lower Health Care Costs Act; Government Purchasing Organizations (GPOs) and anticompetitive behavior; Fiscal Year 2021 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids; COVID-19 Response Efforts and patient monitoring; CARES Act.
Prescription Pricing for the People Act of 2019
Client: MASIMO CORPORATION · Firm: MASIMO CORPORATION
Support for continuous monitoring of patients taking opioids; S.1227, HR 2376 - Prescription Pricing for the People Act of 2019; S 1895: Lower Health Care Costs Act; Government Purchasing Organizations (GPOs) and anticompetitive behavior; H.R. 2740: Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids.
Prescription Pricing for the People Act of 2019
Client: MASIMO CORPORATION · Firm: MASIMO CORPORATION
Support for continuous monitoring of patients taking opioids and patient safety in general; S.1227, HR 2376 - Prescription Pricing for the People Act; S 1895: Lower Health Care Costs Act; Medical device tax; Government Purchasing Organizations (GPOs) and anticompetitive behavior; H.R. 2740: Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids.
Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020
Client: MASIMO CORPORATION · Firm: MASIMO CORPORATION
Support for continuous monitoring of patients taking opioids; S.1227, HR 2376 - Prescription Pricing for the People Act of 2019; S 1895: Lower Health Care Costs Act; Government Purchasing Organizations (GPOs) and anticompetitive behavior; H.R. 2740: Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids.
Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020
Client: MASIMO CORPORATION · Firm: MASIMO CORPORATION
Support for continuous monitoring of patients taking opioids and patient safety in general; S.1227, HR 2376 - Prescription Pricing for the People Act; S 1895: Lower Health Care Costs Act; Medical device tax; Government Purchasing Organizations (GPOs) and anticompetitive behavior; H.R. 2740: Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids.
Prescription Pricing for the People Act of 2019
Client: MASIMO CORPORATION · Firm: MASIMO CORPORATION
Support for continuous monitoring of patients taking opioids; S.1227, HR 2376 - Prescription Pricing for the People Act of 2019; S 1895: Lower Health Care Costs Act; Government Purchasing Organizations (GPOs) and anticompetitive behavior; H.R. 2740: Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids.
Prescription Pricing for the People Act of 2019
Client: MASIMO CORPORATION · Firm: MASIMO CORPORATION
Support for continuous monitoring of patients taking opioids and patient safety in general; S.1227, HR 2376 - Prescription Pricing for the People Act; S 1895: Lower Health Care Costs Act; Medical device tax; Government Purchasing Organizations (GPOs) and anticompetitive behavior; H.R. 2740: Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids.
Support for continuous monitoring of patients taking opioids; S.1227, HR 2376 - Prescription Pricing for the People Act of 2019; S 1895: Lower Health Care Costs Act; Government Purchasing Organizations (GPOs) and anticompetitive behavior; H.R. 2740: Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids.
Support for continuous monitoring of patients taking opioids and patient safety in general; S.1227, HR 2376 - Prescription Pricing for the People Act; S 1895: Lower Health Care Costs Act; Medical device tax; Government Purchasing Organizations (GPOs) and anticompetitive behavior; H.R. 2740: Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids.
Issues related to medical device reprocessing; Support for improving patient safety in hospitals
Issues related to increased tariffs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASIMO CORPORATION via MASIMO CORPORATION
2025 · fourth_quarter · Q4
Issues related to medical device reprocessing; Support for improving patient safety in hospitals
Issues related to tariffs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASIMO CORPORATION via MASIMO CORPORATION
2025 · third_quarter · Q3
Issues related to medical device reprocessing; Support for improving patient safety in hospitals
Issues related to tariffs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASIMO CORPORATION via MASIMO CORPORATION
2025 · second_quarter · Q2
Support of legislation to mandate continuous monitoring for patients taking opioids; Patient safety policy and legislation; Remote patient monitoring technology and telehealth Medicare coverage
Issues related to increased tariffs
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
MASIMO CORPORATION via MASIMO CORPORATION
2025 · first_quarter · Q1
Support of legislation to mandate continuous monitoring for patients taking opioids; Patient safety policy and legislation; Remote patient monitoring technology and telehealth Medicare coverage
Issues related to increased tariffs
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
MASIMO CORPORATION via MASIMO CORPORATION
2024 · fourth_quarter · Q4
Issues related to intellectual property and anti-competitive behavior in the medical device supply chain
Support of legislation to mandate continuous monitoring for patients taking opioids; Patient safety policy and legislation; Remote patient monitoring technology and telehealth Medicare coverage
Issues related to increased tariffs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASIMO CORPORATION via MASIMO CORPORATION
2024 · third_quarter · Q3
Issues related to intellectual property and anti-competitive behavior in the medical device supply chain
Support for using medical technology in opioid safety and recovery; Support of legislation to mandate continuous monitoring for patients taking opioids; Patient safety policy and legislation; Remote patient monitoring technology Medicare coverage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASIMO CORPORATION via MASIMO CORPORATION
2024 · second_quarter · Q2
Support for using medical technology in opioid safety and recovery; Support of legislation to mandate continuous monitoring for patients taking opioids; Patient safety policy and legislation; Remote patient monitoring technology Medicare coverage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASIMO CORPORATION via MASIMO CORPORATION
2024 · first_quarter · 1A
Support for monitoring of patients taking opioids, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Support of legislation to mandate continuous monitoring for patients taking opioids; Support for policies and legislation to alleviate healthcare worker burnout with the use of medical technology; Patient safety policy and legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASIMO CORPORATION via MASIMO CORPORATION
2024 · first_quarter · Q1
Support for monitoring of patients taking opioids, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Support of legislation to mandate continuous monitoring for patients taking opioids; Support for policies and legislation to alleviate healthcare worker burnout with the use of medical technology; Patient safety policy and legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASIMO CORPORATION via MASIMO CORPORATION
2023 · fourth_quarter · Q4
Support for monitoring of patients taking opioids, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Support for adequate coverage and reimbursement in Medicare coverage and reimbursement for medical devices; Support of legislation to mandate continuous monitoring for patients taking opioids; Support for policies and legislation to alleviate healthcare worker burnout with the use of medical technology; Patient safety policy and legislation; Remote patient monitoring technology Medicare coverage
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
MASIMO CORPORATION via MASIMO CORPORATION
2023 · third_quarter · Q3
Support for monitoring of patients taking opioids, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Support for adequate coverage and reimbursement in Medicare coverage and reimbursement for medical devices; Support of legislation to mandate continuous monitoring for patients taking opioids; Support for policies and legislation to alleviate healthcare worker burnout with the use of medical technology; Patient safety policy and legislation; Remote patient monitoring technology Medicare coverage; Support for Medicare coverage and reimbursement pathway for breakthrough technologies (TCET)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASIMO CORPORATION via MASIMO CORPORATION
2023 · second_quarter · Q2
Support for monitoring of patients taking opioids, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Support for adequate coverage and reimbursement in Medicare coverage and reimbursement for medical devices; Support of legislation to mandate continuous monitoring for patients taking opioids; Support for policies and legislation to alleviate healthcare worker burnout with the use of medical technology; Patient safety policy and legislation; Remote patient monitoring technology Medicare coverage; Support for Medicare coverage and reimbursement pathway for breakthrough technologies (TCET)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASIMO CORPORATION via MASIMO CORPORATION
2023 · first_quarter · Q1
Support for monitoring of patients taking opioids, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Support for adequate coverage and reimbursement in Medicare coverage and reimbursement for medical devices; Support of Rep. Kuster/Emmer legislation to mandate continuous monitoring for patients taking opioids; Support for policies and legislation to alleviate healthcare worker burnout with the use of medical technology; Patient safety policy and legislation; Remote patient monitoring technology Medicare coverage; Support for Medicare coverage and reimbursement pathway for breakthrough technologies (TCET)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASIMO CORPORATION via MASIMO CORPORATION
2022 · fourth_quarter · Q4
Support for monitoring of patients taking opioids, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Government Purchasing Organizations (GPOs) and anti-competitive behavior in the medical device supply chain; Support of Rep. Kuster/Emmer legislation to mandate continuous monitoring for patients taking opioids; Support for policies and legislation to alleviate healthcare worker burnout with the use of medical technology; Support for Medicare coverage and reimbursement pathway for breakthrough technologies (TCET); Patient safety policy and legislation; Remote patient monitoring technology Medicare coverage and reimbursement and pilot projects.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), Patent & Trademark Office (PTO), SENATE, White House Office
MASIMO CORPORATION via MASIMO CORPORATION
2022 · third_quarter · Q3
Support for opioid safety consumer education and warning labels and International Overdose Awareness Day; Support for monitoring of patients taking opioids, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Government Purchasing Organizations (GPOs) and anti-competitive behavior in the medical device supply chain; Support of Rep. Kuster legislation to mandate continuous monitoring for patients taking opioids; Support for policies and legislation to alleviate healthcare worker burnout with the use of medical technology; Patient safety policy and legislation; Remote patient monitoring technology Medicare coverage and reimbursement and pilot projects.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, White House Office
MASIMO CORPORATION via MASIMO CORPORATION
2022 · second_quarter · Q2
Support for the use of medical technology for monitoring of patients taking opioids and the use of technology for withdrawal symptoms, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Support for public education on the dangers of opioid induced respiratory depression and monitoring of patients taking opioids, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Government Purchasing Organizations (GPOs) and anti-competitive behavior in the medical device supply chain; Remote patient monitoring technology; Medicare coverage and reimbursement; Support for regulatory oversight of antitrust violations/anticompetitive behavior;
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
MASIMO CORPORATION via MASIMO CORPORATION
2022 · first_quarter · Q1
Need for expedited process; more immigrant visas
Support for the use of medical technology for monitoring of patients taking opioids and the use of technology for withdrawal symptoms, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Support for public education on the dangers of opioid induced respiratory depression and monitoring of patients taking opioids, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Government Purchasing Organizations (GPOs) and anti-competitive behavior in the medical device supply chain; Remote patient monitoring technology; Medicare coverage and reimbursement; Support for regulatory oversight of antitrust violations/anticompetitive behavior;
MASIMO CORPORATION via MASIMO CORPORATION
2021 · fourth_quarter · Q4
Support for patent reform
Support for monitoring of patients taking opioids, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Government Purchasing Organizations (GPOs) and anti-competitive behavior in the medical device supply chain; Remote patient monitoring technology; Medicare coverage and reimbursement
Dangers of reprocessed medical devices
MASIMO CORPORATION via MASIMO CORPORATION
2021 · third_quarter · Q3
Support for patent reform
Oppose SALT deduction cap; oppose increases in capital gains tax.
Support for monitoring of patients taking opioids, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Government Purchasing Organizations (GPOs) and anti-competitive behavior in the medical device supply chain; Fiscal Year 2022 Labor-Health and Human Services, Education spending bill: Study of continuous monitoring for patients taking opioids; Remote patient monitoring technology; Medicare coverage and reimbursement and pilot projects
MASIMO CORPORATION via MASIMO CORPORATION
2021 · second_quarter · Q2
Support for monitoring of patients taking opioids, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Government Purchasing Organizations (GPOs) and anti-competitive behavior in the medical device supply chain; Fiscal Year 2022 Labor-Health and Human Services, Education spending bill: Study of continuous monitoring for patients taking opioids; Remote patient monitoring technology; Medicare coverage and reimbursement and pilot projects
Support for patent reform
Dangers of reprocessed medical devices
MASIMO CORPORATION via MASIMO CORPORATION
2021 · first_quarter · Q1
Support for continuous monitoring of patients taking opioids and patient safety in general; Government Purchasing Organizations (GPOs) and anti-competitive behavior in the medical device supply chain; Fiscal Year 2022 Labor-Health and Human Services, Education spending bill: Study of continuous monitoring for patients taking opioids; Remote patient monitoring technology; Medicare coverage and reimbursement and pilot projects
Support for patent reform
Dangers of reprocessed medical devices
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
MASIMO CORPORATION via MASIMO CORPORATION
2020 · fourth_quarter · Q4
Opposition to the Administrations actions banning certain visas
Dangers of reprocessed medical devices
Support for continuous monitoring of patients taking opioids and patient safety in general; Government Purchasing Organizations (GPOs) and anti-competitive behavior in the medical device supply chain; Fiscal Year 2021 Labor-Health and Human Services, Education spending bill: Study of continuous monitoring for patients taking opioids; Remote patient monitoring technology; Medicare coverage and reimbursement and pilot projects
MASIMO CORPORATION via MASIMO CORPORATION
2020 · third_quarter · Q3
Support for continuous monitoring of patients taking opioids and patient safety in general; Government Purchasing Organizations (GPOs) and anti-competitive behavior in the medical device supply chain; Fiscal Year 2021 Labor-Health and Human Services, Education spending bill: Proposed study of continuous monitoring for patients taking opioids; COVID19 Response Efforts and patient monitoring; CARES Act; Hospital Quality Report Transparency; Remote patient monitoring technology Medicare coverage and reimbursement and pilot projects
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASIMO CORPORATION via MASIMO CORPORATION
2020 · second_quarter · Q2
Immigration - opposition to the President's changes to visa and other immigration policies
Support for continuous monitoring of patients taking opioids and patient safety in general; Government Purchasing Organizations (GPOs) and anti-competitive behavior in the medical device supply chain; Fiscal Year 2021 Labor-Health and Human Services, Education spending bill: Proposed study of continuous monitoring for patients taking opioids; COVID19 Response Efforts and patient monitoring; CARES Act; Hospital Quality Report Transparency; Remote patient monitoring technology Medicare coverage and reimbursement and pilot projects
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MASIMO CORPORATION via MASIMO CORPORATION
2020 · first_quarter · Q1
Support for continuous monitoring of patients taking opioids and patient safety in general; S.1227, HR 2376 - Prescription Pricing for the People Act; S 1895: Lower Health Care Costs Act; Government Purchasing Organizations (GPOs) and anticompetitive behavior; Fiscal Year 2021 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids; COVID-19 Response Efforts and patient monitoring; CARES Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, White House Office
MASIMO CORPORATION via MASIMO CORPORATION
2019 · fourth_quarter · Q4
Support for continuous monitoring of patients taking opioids and patient safety in general; S.1227, HR 2376 - Prescription Pricing for the People Act; S 1895: Lower Health Care Costs Act; Medical device tax; Government Purchasing Organizations (GPOs) and anticompetitive behavior; H.R. 2740: Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, White House Office
MASIMO CORPORATION via MASIMO CORPORATION
2019 · third_quarter · Q3
Support for continuous monitoring of patients taking opioids; S.1227, HR 2376 - Prescription Pricing for the People Act of 2019; S 1895: Lower Health Care Costs Act; Government Purchasing Organizations (GPOs) and anticompetitive behavior; H.R. 2740: Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MASIMO CORPORATION via MASIMO CORPORATION
2019 · second_quarter · RR
Medical technology; patent legislation and law; data sharing; patient safety
Support for patent reform
Oppose SALT deduction cap; oppose increases in capital gains tax; support amortization of R&D provision/legislation.
Dangers of reprocessed medical devices
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Need for expedited process; more immigrant visas
Oppose SALT deduction cap; oppose increases in capital gains tax; support amortization of R&D provision/legislation.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Dangers of reprocessed medical devices
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Oppose SALT deduction cap; oppose increases in capital gains tax.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE